Last updated: 6 August 2024 at 5:36pm EST

Jacob A Orville Net Worth




The estimated Net Worth of Jacob A Orville is at least $2.13 millió dollars as of 30 April 2024. Jacob Orville owns over 102 units of Exact Sciences stock worth over $925,893 and over the last 5 years Jacob sold EXAS stock worth over $1,203,594.

Jacob Orville EXAS stock SEC Form 4 insiders trading

Jacob has made over 18 trades of the Exact Sciences stock since 2020, according to the Form 4 filled with the SEC. Most recently Jacob sold 102 units of EXAS stock worth $6,135 on 30 April 2024.

The largest trade Jacob's ever made was exercising 10,197 units of Exact Sciences stock on 23 February 2022 worth over $653,832. On average, Jacob trades about 2,882 units every 67 days since 2020. As of 30 April 2024 Jacob still owns at least 14,440 units of Exact Sciences stock.

You can see the complete history of Jacob Orville stock trades at the bottom of the page.



What's Jacob Orville's mailing address?

Jacob's mailing address filed with the SEC is C/O EXACT SCIENCES CORP., 5505 ENDEAVOR LANE, MADISON, WI, 53719.

Insiders trading at Exact Sciences

Over the last 21 years, insiders at Exact Sciences have traded over $118,141,352 worth of Exact Sciences stock and bought 191,930 units worth $1,451,887 . The most active insiders traders include Kevin T Conroy, Edwin M Jr Kania és Maneesh Arora. On average, Exact Sciences executives and independent directors trade stock every 12 days with the average trade being worth of $1,667,056. The most recent stock trade was executed by Brian Baranick on 5 August 2024, trading 2,712 units of EXAS stock currently worth $173,893.



What does Exact Sciences do?

exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society task force on colorectal cancer. for more information on exact sciences'​ noninvasive colon cancer screening test, visit cologuardtest.com



Complete history of Jacob Orville stock trades at Exact Sciences

Az érdekelt
Trans.
Tranzakció
Teljes ár
Jacob A Orville
EVP, GM és Screening
Eladás $6,135
30 Apr 2024
Jacob A Orville
EVP, GM és Screening
Opció Gyakorlat $271,772
29 Feb 2024
Jacob A Orville
EVP, GM és Screening
Opció Gyakorlat $227,395
26 Feb 2024
Jacob A Orville
EVP, GM és Screening
Eladás $60,557
21 Feb 2024
Jacob A Orville
EVP, GM és Screening
Opció Gyakorlat $141,040
20 Feb 2024
Jacob A Orville
EVP, GM és Screening
Opció Gyakorlat $126,105
14 Feb 2024
Jacob A Orville
EVP, GM és Screening
Eladás $400,000
10 May 2023
Jacob A Orville
EVP, GM és Screening
Eladás $325,000
3 Mar 2023
Jacob A Orville
EVP, GM és Screening
Eladás $411,901
27 Feb 2023
Jacob A Orville
EVP, GM és Screening
Opció Gyakorlat $361,250
21 Feb 2023
Jacob A Orville
EVP, GM és Screening
Opció Gyakorlat $133,006
14 Feb 2023
Jacob A Orville
EVP, GM és Screening
Opció Gyakorlat $703,491
23 Feb 2022
Jacob A Orville
EVP, GM és Screening
Opció Gyakorlat $165,042
22 Feb 2022
Jacob A Orville
EVP, GM és Screening
Opció Gyakorlat $270,500
18 Feb 2022
Jacob A Orville
EVP, GM és Screening
Opció Gyakorlat $159,010
14 Feb 2022
Jacob A Orville
EVP, GM és Screening
Opció Gyakorlat $516,881
18 Feb 2021
Jacob A Orville
EVP, GM és Screening
Opció Gyakorlat $313,188
16 Feb 2021
Jacob A Orville
EVP, GM és Screening
Opció Gyakorlat $363,341
18 Feb 2020


Exact Sciences executives and stock owners

Exact Sciences executives and other stock owners filed with the SEC include: